| Literature DB >> 33242313 |
Kevin L Chow1, Xane Peters1, Hassan Mashbari2, Mohammad Shokouh-Amiri1, Martin Benjamin1, Michael Warso1.
Abstract
BACKGROUND Eccrine porocarcinoma (EPC) was first described in 1963 as an epidermotropic eccrine carcinoma. Fifty years later, its etiology remains poorly understood. The infrequent nature of this disease merits further inquiry into its etiology, presentation, and standards of management. Furthermore, the propensity for metastasis, which may be as high as 31% on presentation, increases the importance of investigating this rare disease. CASE REPORT The patient was a 63-year-old mechanic who presented with the lesion as a chronic wound following a chemical exposure. The lesion involved the ulnar aspect of his right palm and had concern for extension to the underlying tendons. He underwent a wide excision extending from the wrist to the proximal interphalangeal joint, preserving the ulnar neurovascular bundle. The hand was reconstructed with an anterolateral thigh fascia perforator flap and a skin graft. He had an excellent functional and cosmetic recovery. Unfortunately, he developed metastases to the lymph nodes, necessitating an axillary lymphadenectomy followed by adjuvant chemoradiation using concurrent cisplatin and docetaxel with radiation for 6 weeks. Follow-up at 18 months found no recurrence. CONCLUSIONS Cases of EPC presenting in the fingers have been managed with amputation of the involved phalanges; however, in addition to obtaining complete excision with negative margins, surgeons who deal with tumors of the hand must also consider the goals of limb preservation, functional preservation, and functional reconstruction. Options for reconstruction following excision include primary closure, dermal regeneration templates, skin grafts, flaps, and free-tissue transfer, depending on what tissue types are needed.Entities:
Mesh:
Year: 2020 PMID: 33242313 PMCID: PMC7703490 DOI: 10.12659/AJCR.925231
Source DB: PubMed Journal: Am J Case Rep ISSN: 1941-5923
Figure 1.Gross image of the eccrine tumor on the ulnar aspect of the right palm.
Figure 2.MRI of the hand demonstrating the eccrine tumor involving the skin and extending into the subcutaneous tissue with stranding and abnormal areas of signal extending to the level of underlying tendons.
Figure 3.Final excision with 1–2 cm margins preserving underlying tendons and neurovascular bundles.
Figure 4.Right anterolateral thigh fascia perforator flap with inflow from the transverse branch of the lateral circumflex artery anastomosed to the radial artery.
Figure 5.(A) H+E staining demonstrating porocarcinoma with nests and islands of tumor cells with irregular anastomosing cords. (B) H+E staining with increased mitotic activity with areas of necrosis. (C) Immunohistochemical staining of CK7. (D) Immunohistochemical staining of CK5/6.
Tumor markers.
| CEA | Positive | Negative | Negative | Positive |
| CKAE1/3 | Positive | Positive | Positive | Negative |
| Cam5.2 | Positive | Positive | Negative | Negative |
| CK5/6 | Positive | Positive | Positive | Negative |
| CK7 | Positive | Positive | Negative | Negative |
| CK19 | Positive | Positive | Positive | Negative |
| EMA | Positive | Negative | Positive | Positive |
| p63 | Positive | Positive | Positive | Negative |
| S100 | Negative | Negative | Negative | Positive |
| CK20 | Negative | Negative | Negative | Negative |
| CD31 | Negative | Negative | Negative | Negative |
| Chromogranin | Negative | Negative | Negative | Negative |
| Her-2/Neu | Negative | Negative | Negative | Negative |
| Melan A | Negative | Negative | Negative | Positive |
| Synaptophysin | Negative | Negative | Negative | Negative |